Asia Pacific Botulinum Toxin Market Size & Outlook
Asia Pacific botulinum toxin market, 2018-2030 (US$M)
Related Markets
Asia Pacific botulinum toxin market highlights
- The Asia Pacific botulinum toxin market generated a revenue of USD 2,028.4 million in 2023.
- The market is expected to grow at a CAGR of 11% from 2024 to 2030.
- In terms of segment, type a was the largest revenue generating product in 2023.
- Type A is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 2,028.4 million |
| Market revenue in 2030 | USD 4,199.8 million |
| Growth rate | 11% (CAGR from 2023 to 2030) |
| Largest segment | Type a |
| Fastest growing segment | Type A |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type A, Type B |
| Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.3% of the global botulinum toxin market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,199.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Botulinum Toxin Market Scope
Botulinum Toxin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific botulinum toxin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.65% in 2023. Horizon Databook has segmented the Asia Pacific botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
China, India, and Japan are the developing economies in this region and have great potential for growth of the BoNT market. With rapidly developing economies, the Asia Pacific facial injectable market is expected to witness rapid growth. This can be attributed to the growing medical tourism industry, especially in these countries.
A large number of aesthetic procedures performed in South Korea, Japan, and China each year are primarily driving the market growth in this region. A large number of aesthetic procedures can be attributed to the easy availability of advanced techniques and cost-effective treatment options.
Asia Pacific’s BoNT market is expected to register a comparatively high CAGR of 14.4% over the forecast period due to the presence of growth opportunities in this region, especially in India, Japan, and China. The presence of a large population coupled with increasing patient awareness and rising disposable income are among the major drivers of the market growth in this region.
Reasons to subscribe to Asia Pacific botulinum toxin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific botulinum toxin market databook
-
Our clientele includes a mix of botulinum toxin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific botulinum toxin market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific botulinum toxin market size, by country, 2018-2030 (US$M)
Asia Pacific Botulinum Toxin Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
